Latest news with #Ophthalmic
Yahoo
15-05-2025
- Business
- Yahoo
India Ophthalmic Devices Market Forecast Report 2025-2033, Competitive Analysis of Alcon, Bausch Health, Carl Zeiss, Meditec, Essilor, Hoya, Johnson & Johnson, Nidek, Topcon
The India Ophthalmology Devices Market is set to grow from USD 661.10 million in 2024 to USD 1.12 billion by 2033, at a CAGR of 6.11%. Key drivers include the rising prevalence of eye diseases, an aging population, and technological advances in ophthalmic devices. Government initiatives and increased healthcare spending further propel growth, while high costs and a lack of trained professionals pose challenges. Regional differences show growth in East, North, and South India with varying access levels and infrastructure development. Indian Ophthalmic Devices Market Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "India Ophthalmic Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to India Ophthalmology Devices Market is on a promising trajectory, projected to rise from USD 661.10 million in 2024 to USD 1.12 billion by 2033, expanding at a CAGR of 6.11% The surge is fueled by increasing eye disease incidences, the elders' growing demographic, and technological advancements in ophthalmic devices. Crucial drivers include the prevalence of cataracts, glaucoma, refractive errors, and diabetic retinopathy, escalating with an aging population and diabetes spread. Enhanced government measures like the National Programme for Control of Blindness (NPCB) and private investments in advancing ophthalmic technologies play pivotal roles. AI-enhanced diagnostics and teleophthalmology significantly extend access in rural regions, while awareness and cost reductions propel market demand. Significant market growth factors encompass the high occurrence of eye disorders in India and technological strides in ophthalmic equipment such as AI-based diagnostics, robotic surgeries, and advanced laser therapies. Breakthrough instruments like optical coherence tomography (OCT) and affordable intraocular lenses (IOLs) broaden the availability of cutting-edge ophthalmic care, enhancing early detection and treatment efficacy. C3 Med-Tech's investment in bringing AI-powered eye screening devices exemplifies such advancements. Government initiatives and rising healthcare investment are central to the market's expansion. The government drives accessibility through programs like the Ayushman Bharat scheme, sponsoring new ophthalmic facilities and insurance coverage increases. The 'Comprehensive Eye Care Programme' in Karnataka aims to benefit underprivileged populations, supported by efforts for innovative ocular devices and solutions. Challenges remain, with the high cost of advanced devices hindering widespread adoption, particularly in rural and semi-urban areas. Limited numbers of experienced ophthalmologists further dilute accessibility, although efforts in teleophthalmology and capacity-building persist. Within specific segments, the intraocular lenses market flourishes due to rising cataract surgeries, offering improved multifocal IOLs. Government initiatives for cost-effective IOLs and domestic production facilitate market growth against a backdrop of heightened cataract surgery awareness. The laser devices market benefits from precision surgeries like LASIK, despite the high costs, with technological development likely to spur future uptake. Demand for ophthalmoscopes and corneal topography systems escalates as conditions like diabetic retinopathy and keratoconus are diagnosed more frequently. Though cost and device availability challenge rural deployment, tech advancements push growth. Contact lenses enjoy increased demand for non-invasive vision correction, fueled by urban lifestyles and disposable income growth, even as educational gaps in lens care persist. The East, North, and South India markets each exhibit distinct growth patterns, supported by government investments, urban infrastructure, and renowned eye care institutions. Companies like Alcon Inc., Bausch Health Companies Inc., and Essilor International SA are instrumental market players deploying robust strategies across the ophthalmic landscape. As these trends unfold, the India Ophthalmology Devices Market is poised to significantly transform eye care services nationwide. Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $661.1 Million Forecasted Market Value (USD) by 2033 $1120 Million Compound Annual Growth Rate 6.1% Regions Covered India Key Topics Covered: 1. Introduction2. Research & Methodology3. Executive Summary4. Market Dynamics5. India Ophthalmic Devices Market6. Market Share7. Surgical Devices8. Diagnostic and Monitoring Devices9. Vision Correction Devices10. Region11. Porter's Five Analysis12. SWOT Analysis13. Company Analysis Alcon Inc. Bausch Health Companies Inc. Carl Zeiss Meditec AG Essilor International SA Hoya Corporation Johnson & Johnson Nidek Co. Ltd Topcon Corporation For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Indian Ophthalmic Devices Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
USA Today
13-05-2025
- Business
- USA Today
Eye care product recall: Search list of impacted items
Hear this story Ophthalmic products were voluntarily recalled due to a manufacturing deviation discovered during an audit by the U.S. Food and Drug Administration, a pharmaceutical company announced. The distributor of the products, AvKARE, said it was notified of the recall issued by BRS Analytical Service LLC, adding that manufacturing deviations "may lead to products of unacceptable quality, and it is not possible to rule out patient risks resulting from use of these products." A notice posted by AvKARE urged consumers to stop using the affected products immediately. The products included in the recall were shipped between May 26, 2023, and April 21, 2025. Here is what you need to know. What products were recalled? Recalled items are listed in the database below, including their national drug code (NDC), lot number and expiration date. Need a break? Play the USA TODAY Daily Crossword Puzzle. What should consumers do? Buyers who may have these recalled products in their inventory are urged to complete a downloadable PDF "Quality to Return" form attached to the recall notice and fax it to 931-292-6229 or email it to customerservice@ Then, the company will send the customer a "Return to Authorization Form" to ship the recalled product back to the listed address to get a full credit, including shipping costs. Fernando Cervantes Jr. is a trending news reporter for USA TODAY. Reach him at and follow him on X @fern_cerv_.
